Related Articles
Icariside II induces apoptosis via inhibition of the EGFR pathways in A431 human epidermoid carcinoma cells
Icariside II ameliorates myocardial ischemia and reperfusion injury by attenuating inflammation and apoptosis through the regulation of the PI3K/AKT signaling pathway
Icariside II protects cardiomyocytes from hypoxia‑induced injury by upregulating the miR‑7‑5p/BTG2 axis and activating the PI3K/Akt signaling pathway
Icariside II inhibits cell proliferation and induces cell cycle arrest through the ROS‑p38‑p53 signaling pathway in A375 human melanoma cells
Icariside II overcomes BRAF inhibitor resistance in melanoma by inducing ROS production and inhibiting MITF